Work

Mp15-12 Phase Ib Trial of Alt-803, an Il-15 Superagonist, Plus Bacillus Calmette Guerin (bcg) for the Treatment of Bcg-naïve Patients With Non-muscle-invasive Bladder Cancer (nmibc).

Year: 2017

Type: article

Study design: Clinical Trial

Source: The Journal of Urology

DOI: 10.1016/j.juro.2017.02.497

Authors: Charles J. Rosser, Jeffrey Nix, Lydia Ferguson, Hing C. Wong

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604763309

FWCI: 1.015

Cites:

Cited by: 6

Related to: 10